|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics显示文摘 | Fumi Karino Naoko Deguchi Hibiki Kanda Miki Ohe Keiichi Kondo Mitsuhiro Tada Takashige Kuraki Nobuhiro Nishimura Hidehiko Moriyama Kazuro Ikawa Norifumi Morikawa Takeshi Isobe | 2013 | Journal of Infection and Chemotherapy2013，，1： | 1 |
| 2 | Noise and vibration reduction techniques for 750m/min elevators 显示文摘 | Koji Okada Nobuhiro Nishimura | 1994 | Mitsubishi Electric Advance1994，3，： | 1 |
| 3 | Identification of the OsOPR7 gene encoding 12-oxophytodienoate reductase involved in the biosynthesis of jasmonic acid in rice显示文摘 | Tomoyuki Tani Hiroyuki Sobajima Kazunori Okada Tetsuya Chujo Shin-ichi Arimura Nobuhiro Tsutsumi Mikio Nishimura Hideharu Seto Hideaki Nojiri Hisakazu Yamane | 2008 | Planta2008，，3： | 1 |
| 4 | Effect of Sho-Saiko-To on the pharmacokinetics and pharmacodynamics of tolbutamide in rats显示文摘 | Nobuhiro Nishimura Kohji Naora Hidenari Hirano | 1998 | Journal of Pharmacy Pharmacology1998，50，2： | 1 |
| 5 | Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging显示文摘 | Kenichi Nakajima Yoshimitsu Yamasaki Hideo Kusuoka Tohru Izumi Atsunori Kashiwagi Ryuzo Kawamori Kazuaki Shimamoto Nobuhiro Yamada Tsunehiko Nishimura | 2009 | European Journal of Nuclear Medicine and Molecular Imaging2009，，12： | 1 |
| 6 | Effect of Chinese herbal meicines on intestinal drug absorption 显示文摘 | Nobuhiro Nishimura | 2005 | Pharm Society of Japan2005，125，4： | 1 |
| 7 | A Chinese traditional medicine, Sho- Saiko- To (Xiao- Chaihu-Tang), reduces the bioavailability of Tolbutamide after oral administration in rats显示文摘 | Nobuhiro Nishimura Kohji Naora Hidenari Hirano | 1999 | American Journal of Chinese Medicine1999，17，： | 1 |
| 8 | Liver cirrhosis in Japan:Future global trends in the era of progressive antiviral therapy显示文摘In Japan,viral hepatitis is the main cause of chronic liver diseases,including liver cirrhosis.Due to the availability of highly effective antiviral drugs in combination with antihepatitis measures,Japan has become one of the most successful countries in the world with regard to hepatitis virus elimination.In Japan,there are many elderly patients who have been infected with hepatitis C virus for a long time,and antihepatitis measures have been in place since the 2000s.Thus,the medical situation in Japan is expected to reflect the future situation in other countries where hepatitis countermeasures have been recently initiated and the infected population is aging.Our nationwide survey clarified the changes in the etiologies of liver cirrhosis in Japan.Although viral hepatitis remains a major cause of liver cirrhosis in Japan,nonviral cirrhosis is suggested to increasingly contribute to the etiologies of liver cirrhosis,as opposed to viral hepatitis‐related liver cirrhosis.The changing etiology of liver cirrhosis in Japan may help to predict future global trends in chronic liver diseases. | Hirayuki Enomoto Tomoyuki Takashima Takashi Nishimura Nobuhiro Aizawa Naoto Ikeda Yukihisa Yuri Mamiko Okamoto Kohei Yoshihara Ryota Yoshioka Shoki Kawata Shogo Ota Ryota Nakano Hideyuki Shiomi Hiroko Iijima | 2022 | Portal Hypertension & Cirrhosis2022，1，3： | 0 |
| 9 | Development of risky varices in alcoholic cirrhosis with a well-maintained nutritional status显示文摘AIM: To compare the nutritional status between alcoholic compensated cirrhotic patients and hepatitis C virus(HCV)-related cirrhotic patients with portal hypertension.METHODS: A total of 21 patients with compensated cirrhosis(14 with HCV-related cirrhosis and seven with alcoholic cirrhosis) who had risky esophageal varices were investigated. In addition to physical variables, including the body mass index, triceps skinfold thickness, and arm-muscle circumference, the nutritional status was also assessed using the levels of pre-albumin(pre-ALB), retinol-binding protein(RBP) and non-protein respiratory quotient(NPRQ) measured with an indirect calorimeter.RESULTS: A general assessment for the nutritional status with physical examinations did not show a significant difference between HCV-related cirrhosis and alcoholic cirrhosis. However, the levels of pre-ALB and RBP in alcoholic compensated cirrhotic patients were significantly higher than those in HCV-related compensated cirrhotic patients. In addition, the frequency of having a normal nutritional status(NPRQ ≥ 0.85 and ALB value > 3.5 g/d L) in alcoholic compensated cirrhotic patients was significantly higher than that in HCV-related compensated cirrhotic patients.CONCLUSION: According to our small scale study, alcoholic compensated cirrhotic patients can develop severe portal hypertension even with a relatively well-maintained liver function and nutritional status compared with HCV-related cirrhosis. | Hirayuki Enomoto Yoshiyuki Sakai Yoshinori Iwata Ryo Takata Nobuhiro Aizawa Naoto Ikeda Kunihiro Hasegawa Chikage Nakano Takashi Nishimura Kazunori Yoh Akio Ishii Tomoyuki Takashima Hiroki Nishikawa Hiroko Iijima Shuhei Nishiguchi | 2015 | World Journal of Hepatology2015，7，21： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员